Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis

source extracted confidence: high 2026-04-09
#humans #dermatitis-atopic #antibodies-monoclonal-humanized #janus-kinase-inhibitors #severity-of-illness-index

Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis

Manzar et al., 2024 | J Am Acad Dermatol | Meta Analysis

Citation

Manzar Daud, Suntres Emmanuel, ... Abu-Hilal Mohannad. Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis. J Am Acad Dermatol. 2024-Jul;91(1):168-169. doi:10.1016/j.jaad.2024.03.027

Abstract

No abstract available

Key Findings

Requires manual extraction from full text

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Humans
  • Dermatitis, Atopic
  • Antibodies, Monoclonal, Humanized
  • Janus Kinase Inhibitors
  • Severity of Illness Index
  • Creatine Kinase
  • Nitriles
  • Pyrimidines
  • Piperidines

Evidence Classification

  • Level: Meta Analysis
  • Publication Types: Systematic Review, Meta-Analysis, Letter
  • Vertical: creatine

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09